These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2526764)

  • 1. Cardiac performance and plasma lipids of omega-3 fatty acid-treated streptozocin-induced diabetic rats.
    Black SC; Katz S; McNeill JH
    Diabetes; 1989 Aug; 38(8):969-74. PubMed ID: 2526764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of omega-3 fatty acid treatment on cardiac phospholipid composition and coronary flow of streptozocin-diabetic rats.
    Black SC; Katz S; McNeill JH
    Metabolism; 1993 Mar; 42(3):320-6. PubMed ID: 8487650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of probucol on impaired cardiac performance and lipid metabolism in streptozotocin-induced diabetic rats.
    Tada H; Oida K; Kutsumi Y; Shimada Y; Nakai T; Miyabo S
    J Cardiovasc Pharmacol; 1992 Aug; 20(2):179-86. PubMed ID: 1381008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of diabetes-induced myocardial dysfunction in rats by methyl palmoxirate and triiodothyronine treatment.
    Tahiliani AG; McNeill JH
    Can J Physiol Pharmacol; 1985 Aug; 63(8):925-31. PubMed ID: 2934121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of L-carnitine treatment on lipid metabolism and cardiac performance in chronically diabetic rats.
    Rodrigues B; Xiang H; McNeill JH
    Diabetes; 1988 Oct; 37(10):1358-64. PubMed ID: 2970982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of myo-inositol and T3 on myocardial lipids and cardiac function in streptozocin-induced diabetic rats.
    Xiang H; Heyliger CE; McNeill JH
    Diabetes; 1988 Nov; 37(11):1542-8. PubMed ID: 3181644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender related differential effects of Omega-3E treatment on diabetes-induced left ventricular dysfunction.
    Tuncay E; Seymen AA; Tanriverdi E; Yaras N; Tandogan B; Ulusu NN; Turan B
    Mol Cell Biochem; 2007 Oct; 304(1-2):255-63. PubMed ID: 17530185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of chronic alloxan- and streptozotocin-induced diabetes on isolated rat heart performance.
    Vadlamudi RV; Rodgers RL; McNeill JH
    Can J Physiol Pharmacol; 1982 Jul; 60(7):902-11. PubMed ID: 6215114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial performance in conscious streptozotocin diabetic rats.
    Borges GR; de Oliveira M; Salgado HC; Fazan R
    Cardiovasc Diabetol; 2006 Dec; 5():26. PubMed ID: 17144912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats.
    Ceylan-Isik A; Hünkar T; Aşan E; Kaymaz F; Ari N; Söylemezoğlu T; Renda N; Soncul H; Bali M; Karasu C;
    J Pharm Pharmacol; 2007 Dec; 59(12):1629-41. PubMed ID: 18053324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac function in spontaneously diabetic BB rats treated with low and high dose insulin.
    Rodrigues B; McGrath GM; McNeill JH
    Can J Physiol Pharmacol; 1989 Jun; 67(6):629-36. PubMed ID: 2673499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A newly synthesised molybdenum/ascorbic acid complex alleviates some effects of cardiomyopathy in streptozocin-induced diabetic rats.
    MacDonald K; Bailey J; MacRory C; Friis C; Vogels CM; Broderick T; Westcott SA
    Drugs R D; 2006; 7(1):33-42. PubMed ID: 16620135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of free fatty acids and dichloroacetate on isolated working diabetic rat heart.
    Nicholl TA; Lopaschuk GD; McNeill JH
    Am J Physiol; 1991 Oct; 261(4 Pt 2):H1053-9. PubMed ID: 1928388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral administration of sodium tungstate improves cardiac performance in streptozotocin-induced diabetic rats.
    Nagareddy PR; Vasudevan H; McNeill JH
    Can J Physiol Pharmacol; 2005 May; 83(5):405-11. PubMed ID: 15897922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional and ultrastructural analysis of experimental diabetic rat myocardium. Manifestation of a cardiomyopathy.
    Jackson CV; McGrath GM; Tahiliani AG; Vadlamudi RV; McNeill JH
    Diabetes; 1985 Sep; 34(9):876-83. PubMed ID: 3896897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hydralazine on myocardial plasma membrane fatty acid binding protein (PM-FABP) during diabetes mellitus.
    Heyliger CE; Powell DM; Skau KA
    Mol Cell Biochem; 1995 Jul; 148(1):39-44. PubMed ID: 7476932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cardiac microsomal sarcoplasmic reticulum prepared from control and diabetic rats.
    Lopaschuk GD; Katz S; McNeill JH
    J Pharmacol Methods; 1983 Nov; 10(3):199-206. PubMed ID: 6228695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of propionyl-L-carnitine on cardiac dysfunction in streptozotocin-diabetic rats.
    Terada R; Matsubara T; Koh N; Nakamura J; Hotta N
    Eur J Pharmacol; 1998 Sep; 357(2-3):185-91. PubMed ID: 9797035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac function in spontaneously hypertensive diabetic rats.
    Rodrigues B; McNeill JH
    Am J Physiol; 1986 Sep; 251(3 Pt 2):H571-80. PubMed ID: 2944394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lusitropic effect of MCC-135 is associated with improvement of sarcoplasmic reticulum function in ventricular muscles of rats with diabetic cardiomyopathy.
    Satoh N; Sato T; Shimada M; Yamada K; Kitada Y
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1161-6. PubMed ID: 11504815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.